What can we help you find?
The PHARM-CHF trial investigated whether regularly seeing a pharmacist improves adherence to heart failure medications.
Top news of the day from across the health care landscape
“The central problem in heart failure is not that patients are short of breath or retain fluid. The problem is that they die.”
The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
This may be the first drug shown to reduce mortality in the HFpEF population in the United States but will hopefully not be the last.
A number of landmark clinical studies on lipid lowering and cardiovascular health have been published, shaping how patients are treated.
Large clinical trial shows no increase in adverse events from treatment with aspirin for heart failure.
Even small weight gain may change the structure of the heart.
While overall hospitalizations for heart failure decreased, problems persist among minority populations.
This article highlights 5 published case reports that document unusual drug overdoses.
Investigational cancer drug blocks inflammation and fibrosis in heart cells.
+ Load More